Antisense & nucleic acid drug development. Antisense Nucleic Acid Drug Dev
Saved in:
Language: | Inglés |
---|---|
ISSN: | 1087-2906 |
Published: |
Larchmont, NY :
Mary Ann Liebert, Inc.,
c1996-c2003.
|
Subjects: | |
Online Access: | http://www.liebertonline.com/oli |
Related Items: | Continues:
Antisense research and development Continued by: Oligonucleotides |
LEADER | 01689cas a2200433 a 4500 | ||
---|---|---|---|
001 | 9606142 | ||
003 | DNLM | ||
005 | 20130509062651.0 | ||
007 | cr|cnu|||||||| | ||
008 | 960523d19962003nyubr p 0 0eng | ||
010 | |a 96646751 | ||
022 | 0 | |a 1087-2906 |l 1087-2906 | |
030 | |a ANADF5 | ||
035 | |a (DNLM)SR0088317(s) | ||
035 | |a (OCoLC)34246031 | ||
040 | |a DNLM |c DNLM | ||
060 | 0 | 0 | |a W1 |b AN887 |
210 | 1 | 0 | |a Antisense Nucleic Acid Drug Dev |2 DNLM |
222 | 0 | |a Antisense and nucleic acid drug development | |
245 | 0 | 0 | |a Antisense & nucleic acid drug development. |
246 | 3 | |a Antisense and nucleic acid drug development | |
260 | |a Larchmont, NY : |b Mary Ann Liebert, Inc., |c c1996-c2003. | ||
300 | |a 8 v. : |b ill. | ||
310 | |a Bimonthly | ||
321 | |a Quarterly |b 1996 | ||
362 | 0 | |a Vol. 6, no. 1 (spring 1996)-v. 13, no. 3 (June 2003) | |
510 | 1 | |9 4 |a Index medicus |x 0019-3879 |b v6n1,spring 1996-v13n3,June 2003 | |
510 | 1 | |9 4 |a MEDLINE |b v6n1,spring 1996-v13n3,June 2003 | |
510 | 1 | |9 4 |a PubMed |b v6n1,spring 1996-v3n3,June 2003 | |
530 | |a Also available online. | ||
650 | 2 | |a Antisense Elements (Genetics) |v Periodicals. | |
650 | 2 | |a Gene Expression |x drug effects |v Periodicals. | |
650 | 2 | |a Nucleic Acids |v Periodicals. | |
780 | 0 | 0 | |t Antisense research and development |x 1050-5261 |w (DLC) 91660238 |
785 | 0 | 0 | |t Oligonucleotides |x 1545-4576 |w (OCoLC)52538543 |w (DLC) 2003214918 |
856 | 4 | |u http://www.liebertonline.com/oli | |
910 | |a CJY | ||
999 | |c 88680 |d 88680 | ||
952 | |0 0 |1 0 |4 0 |7 0 |9 2105957 |a CSIC-SURAD |b CSIC-SURAD |h 1996-2003 |o CSIC-SURAD-2105957EJNL-CSIC-1087-2906 |p CSIC-SURAD-2105957EJNL-CSIC-88680 |t 2806821 |y EJNL-CSC |z Mary Ann Liebert, Inc, |